HIGHLIGHTS
- who: Zahra Kanannejad et al. from the University of Zurich, Switzerland have published the research work: Immune checkpoint molecules in prevention and development of asthma, in the Journal: (JOURNAL)
- what: Based on the above considerations, the aim of this review is to provide an updated overview of ICPs and their roles in asthma pathogenesis (summarized in Figure 1), and to assess their implications as therapeutic targets in asthma.
- future: Experimental investigations are needed to understand the cell specific functions of different isoforms of CD200R during homeostatic and inflammatory processes. Regarding the contribution of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.